Purpose To evaluate the safety and efficacy of trabeculectomy with or without mitomycin-C (MMC) in the management of glaucoma in aphakia and pseudophakia following congenital cataract surgery.

The combination of a compromised endothelium and the use of mitomycin-C can cause bullous keratopathy in patients undergoing glaucoma filtering surgery, a recent publication suggests. Holger Mietz, MD ...

Trabeculectomy after failed glaucoma drainage device (GDD) is often thought of as a poor choice due to the possibility of violated conjunctiva leading to failure of the trabeculectomy. Thus, no large ...

The gold standard of surgical management of patients with open-angle glaucoma is trabeculectomy with an adjunctive antifibrotic agent. Although bleb-forming surgeries reduce intraocular pressure (IOP) ...

The goal of glaucoma surgery should be the preservation of visual function, the avoidance of sight-threatening complications, and the preservation of the quality of life of the patient. Curiously, the ...

The addition of an intravitreal anti-VEGF agent at the time of trabeculectomy may result in more favorable bleb characteristics compared with mitomycin C alone. The results of a pilot study by Malik Y ...

A new report suggests corticosteroids likely are not a panacea for ocular surface disease, a potential adverse effect of trabeculectomy. Patients who took steroid eye drops before trabeculectomy for ...

More than half of people getting a certain type of glaucoma surgery may suffer from temporary, sometimes severe vision loss afterwards, suggests a new study. A smaller proportion, about 8 in every 100 ...